BRIEF-Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics
Reuters
Nov 05
BRIEF-Co-Diagnostics Engages Maxim Group to Pursue SPAC Transaction for its Indian Joint Venture, CoSara Diagnostics
Nov 5 (Reuters) - Co-Diagnostics Inc CODX.O:
CO-DIAGNOSTICS ENGAGES MAXIM GROUP TO PURSUE SPAC TRANSACTION FOR ITS INDIAN JOINT VENTURE, COSARA DIAGNOSTICS PVT. LTD
Source text: ID:nPn60cpSWa
Further company coverage: CODX.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.